AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumour tissue identified the…
Browsing: AACR
AACR 2021: Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk
Men who had a high genetic risk of developing prostate cancer were less likely to…
AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with melanoma
Tumour mutational burden (TMB) was an accurate predictor of response to treatment with immune checkpoint…
AACR 2021: Liquid biopsy augments MRI for predicting response to neoadjuvant treatment in patients with breast cancer
A liquid biopsy test to assess plasma cell-free DNA (cfDNA) integrity could improve the accuracy…
AACR 2021: Ovarian cancer patients face increased risk of mental illness
Women diagnosed with ovarian cancer were more than three times more likely than the general…
AACR 2021: Cancer-killing virus therapy shows promise against inoperable skin cancers
Early results show that a new combination drug therapy is safe and effective against advanced…
AACR 2021: Novel immunotherapy approach to fight melanoma
In a new study led by Yale Cancer Center, USA, researchers have advanced a tumour-targeting…
AACR 2021: Study shows young early-onset colorectal cancer patients have increased survival
New research by Yale Cancer Center, USA, shows patients with early-onset colorectal cancer, age 50…
AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer
Lower levels of cancer aneuploidy were associated with more favourable outcomes after immune checkpoint inhibition…
AACR 2021: Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack…